Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading biotech company in London seeks a Senior Scientist to develop multicellular disease models and support target validation. This role involves designing complex cellular models, analyzing data, and collaborating with interdisciplinary teams to advance healthcare innovations. Join a dynamic environment committed to scientific excellence and impactful research.
Join to apply for the Senior Scientist - Multicellular Disease Models – Target Validation role at Relation.
About Relation
Relation is an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in unprecedented ways, discovering therapies to treat some of life’s most devastating diseases. We leverage single-cell multi-omics directly from patient tissue, functional assays, and machine learning to drive disease understanding, from cause to cure.
We are rapidly scaling our technology and discovery teams, offering a unique opportunity to join one of the most innovative biotech companies. Our state-of-the-art laboratories in London foster interdisciplinarity and turn groundbreaking ideas into positive impacts for patients.
We are committed to diversity and inclusion, and as an equal opportunities employer, we do not discriminate based on gender, ethnicity, or other protected characteristics. Join us to be part of a talented team that advances drug discovery and impacts patient lives.
We seek a Senior Scientist in Multicellular Disease Models to develop disease-relevant multicellular models with multi-parametric endpoints, support target validation experiments, analyze scientific data, and maintain laboratory operations. You will contribute to research and project success, collaborating with wet-lab scientists and data scientists, and helping shape our organizational culture.
Join us in this exciting role to impact genetics, disease risk, and deliver transformative medicines. Together, we set new standards in machine learning and genetics. The patient awaits!